Medicare Part D coverage · insulin aspart-szjj · RxCUI 2705739
insulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog]
Per the CMS 2026 Part D formulary file, insulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog] is covered by 339 Medicare Part D plans (6.7% of enrollable products), averaging Tier 3.4, with prior authorization required on 12.5% of covering formularies.
- 6.7%
- Plan coverage
- 339
- Plans covering
- T3.4
- Avg tier
- 12.5%
- Prior auth required
What the CMS Formulary Data Shows for insulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog]
Per the CMS 2026 Part D formulary file, insulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog] (RxNorm concept RXCUI 2705739, generic name insulin aspart-szjj) appears on 8 distinct formulary files spanning 339 Medicare Part D plan offerings - 6.7% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 3 to Tier 6, with a cross-plan average of Tier 3.4.
Real-world access to insulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog] depends on utilization management as much as tier placement: 12.5% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 418,431 Part D beneficiaries filled insulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog] in 2023, with total plan-and-beneficiary spending of $1,208,385,334 and an average per-beneficiary annual cost of $2,887.90. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry insulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog] today.
Coverage Details
- Formularies covering
- 8
- Plans covering
- 339
- Coverage rate
- 6.7%
- Tier range
- Tier 3 – Tier 6
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 12.5% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 418,431
- Total spending
- $1,208,385,334
- Avg per beneficiary
- $2,887.90
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering insulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Wellcare Simple (HMO-POS) | Coordinated Care OF Washington, Inc. | T3 | No | $0 | WA |
| Wellcare Simple Open (PPO) | Wellcare OF Mississippi, Inc. | T3 | No | $0 | MS |
| Wellcare Simple Open (PPO) | Wellcare OF Georgia, Inc. | T3 | No | $0 | GA |
| Wellcare Simple (HMO) | Wellcare OF Texas, Inc. | T3 | No | $0 | TX |
| Wellcare Simple (HMO) | Wellcare OF Texas, Inc. | T3 | No | $0 | TX |
| Wellcare Simple (HMO) | Wellcare OF Texas, Inc. | T3 | No | $0 | TX |
| Wellcare Simple (HMO) | Wellcare OF Texas, Inc. | T3 | No | $0 | TX |
| Wellcare Simple Open (PPO) | Wellcare Health Insurance Company OF America | T3 | No | $0 | AR |
| Wellcare Simple (HMO) | Health NET OF Arizona, Inc. | T3 | No | $0 | AZ |
| Wellcare Simple (HMO) | Health NET OF Arizona, Inc. | T3 | No | $0 | AZ |
| Wellcare Simple Value (HMO) | Health NET OF Arizona, Inc. | T3 | No | $0 | AZ |
| Wellcare Simple (HMO-POS) | Health NET OF Arizona, Inc. | T3 | No | $0 | NV |
| Wellcare Simple (HMO-POS) | Health NET OF Arizona, Inc. | T3 | No | $0 | NV |
| Wellcare Low Premium (HMO) | Health NET OF California, Inc. | T3 | No | $0 | CA |
| Wellcare Simple Focus (HMO) | Health NET OF California, Inc. | T3 | No | $0 | CA |
| Wellcare Simple Focus (HMO) | Health NET OF California, Inc. | T3 | No | $0 | CA |
| Wellcare Low Premium (HMO) | Health NET OF California, Inc. | T3 | No | $0 | CA |
| Wellcare Low Premium (HMO) | Health NET OF California, Inc. | T3 | No | $0 | CA |
| Wellcare Simple (HMO-POS) | Wellcare OF Connecticut, Inc. | T3 | No | $0 | CT |
| Wellcare Giveback (HMO-POS) | Wellcare OF Connecticut, Inc. | T3 | No | $0 | CT |
Show the next 30 plans
| Wellcare Simple (HMO-POS) | Buckeye Community Health Plan, Inc. | T3 | No | $0 | OH |
| Wellcare Low Premium (HMO-POS) | Wellcare Health Plans OF NEW Jersey, Inc. | T3 | No | $0 | NJ |
| Wellcare Giveback (HMO-POS) | Wellcare Health Plans OF NEW Jersey, Inc. | T3 | No | $0 | NJ |
| Wellcare Simple (HMO-POS) | Wellcare Health Plans OF NEW Jersey, Inc. | T3 | No | $0 | NJ |
| Wellcare Simple (HMO) | Sunshine State Health Plan, Inc. | T3 | No | $0 | FL |
| Wellcare Simple (HMO) | Sunshine State Health Plan, Inc. | T3 | No | $0 | FL |
| Wellcare Simple (HMO) | Sunshine State Health Plan, Inc. | T3 | No | $0 | FL |
| Wellcare Simple (HMO) | Sunshine State Health Plan, Inc. | T3 | No | $0 | FL |
| Wellcare Simple (HMO) | Sunshine State Health Plan, Inc. | T3 | No | $0 | FL |
| Wellcare Simple (HMO) | Sunshine State Health Plan, Inc. | T3 | No | $0 | FL |
| Wellcare Simple (HMO) | Sunshine State Health Plan, Inc. | T3 | No | $0 | FL |
| Wellcare Simple (HMO-POS) | Wellcare OF Georgia, Inc. | T3 | No | $0 | GA |
| Wellcare Simple (HMO-POS) | Wellcare OF Georgia, Inc. | T3 | No | $0 | GA |
| Wellcare Simple (HMO-POS) | Wellcare OF Georgia, Inc. | T3 | No | $0 | GA |
| Wellcare Simple (HMO-POS) | Wellcare OF Georgia, Inc. | T3 | No | $0 | GA |
| Wellcare Giveback (HMO-POS) | Nebraska Total Care, Inc. | T3 | No | $0 | NE |
| Wellcare Simple (HMO-POS) | Nebraska Total Care, Inc. | T3 | No | $0 | NE |
| Wellcare Simple Open (PPO) | Nebraska Total Care, Inc. | T3 | No | $0 | NE |
| Wellcare Low Premium (HMO-POS) | Harmony Health Plan, Inc. | T3 | No | $0 | MS |
| Wellcare Simple Preferred (HMO-POS) | Harmony Health Plan, Inc. | T3 | No | $0 | AR |
| Wellcare Simple (HMO-POS) | Harmony Health Plan, Inc. | T3 | No | $0 | MS |
| Wellcare Simple (HMO-POS) | Harmony Health Plan, Inc. | T3 | No | $0 | MS |
| Wellcare Simple (HMO-POS) | Harmony Health Plan, Inc. | T3 | No | $0 | TN |
| Wellcare Simple Value (HMO-POS) | Harmony Health Plan, Inc. | T3 | No | $0 | IL |
| Wellcare Simple (HMO-POS) | Home State Health Plan, Inc. | T3 | No | $0 | MO |
| Wellcare Simple (HMO-POS) | Wellcare OF Iowa, Inc. | T3 | No | $0 | IA |
| Wellcare Simple Open (PPO) | Wellcare Health Insurance OF Connecticut, Inc. | T3 | No | $0 | CT |
| Wellcare Giveback Open (PPO) | Wellcare Health Insurance OF Connecticut, Inc. | T3 | No | $0 | CT |
| Wellcare Simple Open (PPO) | Wellcare Health Insurance OF Connecticut, Inc. | T3 | No | $0 | NC |
| Wellcare Simple Open (PPO) | Meridian Health Plan OF Michigan, Inc. | T3 | No | $0 | MI |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is insulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog] covered by Medicare Part D?
Yes, insulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog] is covered by 339 Medicare Part D plans (6.7% of all Part D formularies).
What tier is insulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog] on Medicare Part D plans?
insulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog] averages Tier 3.4 across Part D plans, ranging from Tier 3 to Tier 6.
Does insulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog] require prior authorization?
12.5% of Part D formularies require prior authorization for insulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on insulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog]?
In 2023, total Medicare Part D spending on insulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog] was $1,208,385,334, covering 418,431 beneficiaries. The average spend per beneficiary was $2,887.90.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- midazolam 50 MG/ML Nasal Spray [Nayzilam] T3.4
- phenytoin sodium 100 MG Extended Release Oral Capsule [Dilantin] T3.4
- leuprolide acetate 22.5 MG Injection T3.4
- mesalamine 500 MG Extended Release Oral Capsule [Pentasa] T3.4
- 1.7 ML denosumab-qbde 70 MG/ML Injection [Xtrenbo] T3.4
- 3 ML insulin aspart-szjj 100 UNT/ML Pen Injector [Merilog] T3.4
Similar prior-authorization rate
- 200 ML fluconazole 2 MG/ML Injection 12.5% PA
- 3 ML insulin glargine-aglr 100 UNT/ML Pen Injector [Rezvoglar] 12.5% PA
- 100 ML fluconazole 2 MG/ML Injection 12.5% PA
- levorphanol tartrate 2 MG Oral Tablet 12.5% PA
- olanzapine 10 MG Injection [Zyprexa] 12.5% PA
- caspofungin acetate 70 MG Injection 12.5% PA